Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 31% ± 15% |
Insufficient scRNA-seq data for expression of MNT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2456.30 | 1445 / 1445 | 100% | 15.99 | 183 / 183 |
intestine | 100% | 2258.91 | 966 / 966 | 100% | 9.87 | 527 / 527 |
ovary | 100% | 2273.03 | 180 / 180 | 100% | 14.17 | 430 / 430 |
prostate | 100% | 2014.69 | 245 / 245 | 100% | 9.48 | 502 / 502 |
skin | 100% | 2121.20 | 1809 / 1809 | 100% | 12.93 | 472 / 472 |
uterus | 100% | 2260.45 | 170 / 170 | 100% | 8.94 | 458 / 459 |
stomach | 100% | 1521.58 | 359 / 359 | 100% | 10.46 | 285 / 286 |
thymus | 100% | 1997.63 | 652 / 653 | 100% | 9.82 | 603 / 605 |
bladder | 100% | 2278.00 | 21 / 21 | 99% | 9.00 | 501 / 504 |
breast | 100% | 1767.50 | 459 / 459 | 99% | 9.25 | 1109 / 1118 |
brain | 99% | 1438.16 | 2609 / 2642 | 100% | 10.20 | 703 / 705 |
kidney | 100% | 1392.85 | 89 / 89 | 98% | 7.87 | 887 / 901 |
lung | 100% | 1791.46 | 577 / 578 | 98% | 9.22 | 1137 / 1155 |
adrenal gland | 100% | 1775.77 | 258 / 258 | 97% | 8.68 | 224 / 230 |
pancreas | 98% | 750.73 | 320 / 328 | 99% | 9.41 | 177 / 178 |
liver | 90% | 607.85 | 203 / 226 | 73% | 3.28 | 296 / 406 |
adipose | 100% | 1888.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 19.38 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.49 | 29 / 29 |
spleen | 100% | 1886.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.67 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.51 | 1 / 1 |
blood vessel | 100% | 2480.30 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1651.50 | 908 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 824.04 | 834 / 861 | 0% | 0 | 0 / 0 |
muscle | 88% | 562.47 | 703 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0090398 | Biological process | cellular senescence |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0051726 | Biological process | regulation of cell cycle |
GO_2001234 | Biological process | negative regulation of apoptotic signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0042802 | Molecular function | identical protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | MNT |
Protein name | MAX network transcriptional repressor Max-binding protein MNT (Class D basic helix-loop-helix protein 3) (bHLHd3) (Myc antagonist MNT) (Protein ROX) |
Synonyms | BHLHD3 ROX |
Description | FUNCTION: Binds DNA as a heterodimer with MAX and represses transcription. Binds to the canonical E box sequence 5'-CACGTG-3' and, with higher affinity, to 5'-CACGCG-3'. |
Accessions | Q99583 V9GY02 ENST00000575394.1 ENST00000174618.5 |